Patents
Patents for C07C 239 - Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof (5,130)
08/2005
08/11/2005WO2005054174A3 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex
08/10/2005CN1653037A Substituted tetracycline compounds
08/10/2005CN1653025A NK1 antagonists
08/03/2005CN1649830A Substituted aryl ketones
08/03/2005CN1648035A Preparation of a high purity and high concentration hydroxylamine free base
08/03/2005CN1213020C Phenylalaninol derivatives
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005US20050163694 Hydroxylammonium sulfate, sodium hydroxide, ammonia; hydroxyanthraquinone stabilizer feed to reactor at a low temperature; fluidized bed ion exchange resin; reduced risks of explosion
07/20/2005CN1211352C Cyclohexenone oxime ether metal salts
07/20/2005CN1211326C Methods and compositions for inhibiting polymerization of ethylenically unsaturated hydrocarbons
07/19/2005US6919481 Alkoxyamines containing a vinyl group, their applications and methods of their production
07/14/2005WO2005063371A2 Use of structured water-soluble polymers obtained by controlled radical polymerization as a dispersant and agent for assisting in the grinding of mineral materials
07/14/2005US20050153958 Substituted aryl ketones
07/14/2005CA2548802A1 Use of structured water-soluble polymers obtained by controlled radical polymerization as a dispersant and agent for assisting in the grinding of mineral materials
07/13/2005EP1551807A1 Improved reagents for n-amination
07/13/2005CN1639201A Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
07/13/2005CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders
07/07/2005WO2005061444A1 Fullerene derivative
07/07/2005WO2005014530A3 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment of diseases
07/07/2005DE10357301A1 Verbindungen zur Modulation des Glykolyse-Enzym- und/oder Transaminase-Komplexes Compounds for modulation of the glycolytic enzyme and / or transaminase complex
07/06/2005EP1549600A1 Ketones
07/05/2005CA2230082C Amide compounds and use thereof
06/2005
06/30/2005WO2005058800A1 Hydroxylamine derivatives
06/30/2005CA2548572A1 Hydroxylamine derivatives
06/23/2005WO2005037771A3 O- substitute hydroxylamines and salts thereof
06/16/2005WO2005054174A2 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex
06/15/2005EP1541547A1 Hydroxylamine derivatives
06/14/2005CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/09/2005US20050124814 Addition polymers
06/08/2005EP0849256B1 Amide compounds and use of the same
06/08/2005CN1205179C (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
06/01/2005EP1534666A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
06/01/2005EP1248761A4 Compounds which mimic the chemical and biological properties of discodermolide
06/01/2005EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
05/2005
05/26/2005US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
05/26/2005US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid
05/19/2005US20050104042 Process for the synthesis of amine ethers from secondary amino oxides
05/18/2005CN1617860A [1.2]-oxazin-3, 5-diones
05/18/2005CN1617849A Hiv整合酶抑制剂 Hiv integrase inhibitors
05/17/2005CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines
05/12/2005US20050101671 Compounds and compositions for delivering active agents
05/10/2005CA2097044C Cyclopentane- and -pentene-.beta.-amino acids
05/05/2005US20050096360 vascular adhesion protein; Allylhydrazine and hydroxylamine (aminooxy) compounds; inflammation, inflammatory diseases and autoimmune disorders, multiple sclerosis
04/2005
04/28/2005WO2005037771A2 O- substitute hydroxylamines and salts thereof
04/27/2005EP1525161A1 Method for producing a solid containing zeolites
04/26/2005US6884907 Containing carboxylic acid groups; diagnosis; prophylaxis
04/21/2005WO2004062601A3 Antibacterial agents
04/21/2005US20050085645 essentially free of hydroxylamine; essentially free of any solvent; extraction, stripping, free-base release or pH adjustment, and distillation
04/21/2005US20050085636 Reacting organoboron compound with oxypiperidine compound
04/20/2005EP1165495B1 Resorcinol derivatives
04/12/2005US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough
04/07/2005US20050075514 Process for the oxidation of organic substrates and a catalyst composition for carrying out the process
04/05/2005US6875861 Process for producing nitrosonium ions
04/05/2005US6875831 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers
03/2005
03/31/2005US20050070707 [1.2]-Oxazin-3,5-diones
03/30/2005EP1311555B1 Acrylate contact adhesive materials having tight molecular weight distribution
03/24/2005US20050065344 Reagents for N-amination
03/24/2005US20050065115 N,N-dihalogenated amino acids and derivatives
03/22/2005US6870058 Polyhydroxy, dienyl lactones and intermediates
03/22/2005CA2311133C Method for producing organic hydroxylamines
03/17/2005WO2005023757A1 Process for production of o-substituted hydroxylamines
03/17/2005CA2535655A1 Process for production of o-substituted hydroxylamines
03/16/2005EP1514873A1 Process for oxidation of organic substrates and catalyst compositions for performing the same
03/10/2005WO2005020896A2 N,n-dihalogenated amino acids and derivatives
03/09/2005CN1592740A Process for the synthesis of amine ethers from secondary amino oxides and its use
03/03/2005WO2005019159A1 OPTICALLY ACTIVE α-AMINOOXYKETONE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF
02/2005
02/24/2005US20050043294 Treating atherosclerosis and other coronary artery diseases; preventing dyslipidemia
02/17/2005WO2005014530A2 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment of diseases
02/17/2005US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy
02/17/2005CA2535403A1 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment of diseases
02/15/2005US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders
02/09/2005EP1503981A2 Substituted tetracycline compounds
02/01/2005CA2362698C Resorcinol derivatives
01/2005
01/27/2005US20050020684 Modulators of peroxisome proliferator activated receptors
01/25/2005US6846813 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
01/19/2005EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
01/13/2005WO2004087650A3 Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-iv inhibitors
01/12/2005EP1495034A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
01/12/2005CN1564782A Stabilized hydroxylamine solutions
01/11/2005US6841703 Polymerization of ethylenically unsaturated monomers with low dispersity
01/05/2005CN1183094C Method for stabilizing N-oxyl compound in vinyl compound
12/2004
12/16/2004WO2004066929A3 Cycloalkyl containing anilide ligands for the thyroid receptor
12/15/2004EP1188742B1 Vinylated alkoxyamine, use thereof, and process for producing the same
12/14/2004US6831173 Process for selective oxidation of primary alcohols and novel carbohydrate aldehydes
12/08/2004EP1483228A1 Nk1 antagonists
12/02/2004WO2004076053A3 Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds
12/02/2004US20040242931 Stabilized hydroxylamine solutions
12/01/2004EP1481012A1 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
12/01/2004EP1480944A2 Substituted aryl ketones
12/01/2004CN1177812C Process for producing isomer mixtures from O-phenoxyalkylhydroxy amines or O-phenoxyalkyloximes
11/2004
11/18/2004US20040229955 Antibacterial agents
11/10/2004EP1475371A1 1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/10/2004CN1174968C 1, 2 -bis -adducts of stable nitroxides with substituted ethylenes and stabilized compositions
11/03/2004CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
10/2004
10/20/2004EP1467965A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
10/20/2004EP1467695A2 Hiv integrase inhibitors
10/20/2004EP1311472B1 Method for preparing alkoxyamines from nitroxides
10/14/2004WO2004087650A2 Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-iv inhibitors
10/14/2004WO2004087643A1 Deformylase inhibitor, process for preparing the same, and antibacterial composition comprising the same
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 52